Phenomenex Launches Spin-Off Company Neoteryx LLC

Jul 18, 2014
By LCGC Editors

Phenomenex Inc. (Torrance, California, USA) has revealed it will be launching a spin-off company focusing on biological sampling called Neoteryx LLC. Neoteryx is an independent company that aims to develop novel technologies and products for the collection, handling, and analysis of biological fluids in the pharmaceutical and clinical industries.

Neoteryx will use volumetric absorptive microsampling (VAMS) technology, developed at Phenomenex, to begin manufacturing products for the collection, handling, and analysis of biological fluids. This technology was developed over four years of internal research and development together with a co-development programme with major American and European pharmaceutical companies.

Mr. Fasha Mahjoor, Neoteryx CEO, commented: “I am excited to introduce Neoteryx, and even more so its novel technologies and products. The Mitra (RUO) Microsampling Device was officially launched at ASMS 2014 in Baltimore, Maryland [USA]. The response was overwhelmingly positive and all indications point to this device revolutionizing and simplifying how biological fluid sampling and analysis is performed”

For more information please visit www.phenomenex.com